Indivior Pharmaceuticals, Inc. INDV
36.28 USD +0.91 +2.57%
At close · Nov 2
36.30 +0.02 +0.06%
After hours · Nov 2, 5:43 PM ET
27.68 52-week range 42.81
- YTD
- +1.11%
- 1 year
- +23.53%
- Open
- 35.43
- Prev close
- 35.37
- Mkt cap
- 4.28B
- Vol
- 4.87M
- Avg vol
- 2.45M
- EPS
- 3.66
- P/E
- 9.91
- Div yield
- 0.00%
More statistics
- Low
- 35.32
- High
- 37.01
- Forward P/E
- 8.05
- Beta
- 1.13
- Short ratio
- 3.89
- Inst. own
- 104.85%
- Dividend
- 0.00
- Ex-div date
- Nov 2, 2026
- Earnings
- Feb 25, 2027
- 50-d avg
- 35.20
- 200-d avg
- 35.66
- 1y target
- 49.50
5D chart
Chart tools
Chart is warming up
The five-day price history for INDV has not been loaded yet. Try again in a moment.
Altman Z-Score
3.70 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 5
- Debt / Equity 1
- P/E 3
- P/B 1
P/E 21.4×
P/S 3.6×
P/B -45.8×
P/FCF -47.7×
EV/EBITDA 15.3×
EV/Sales 3.7×
FCF Yield -2.1%
Gross Margin 80.1%
Operating Margin 21.4%
Net Margin 16.9%
ROE -214.3%
ROIC 70.8%
ROA 17.4%
Revenue 4.3%
Operating Income 728.1%
EPS (diluted) 10833.3%
Free Cash Flow -1980.0%
Current Ratio 0.7×
Quick Ratio 0.5×
Debt / Equity -3.6×
Net Debt / EBITDA 0.5×
Interest Coverage 5.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31